Lucid Diagnostics LUCD Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $195.92M.
The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lucid Diagnostics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lucid Diagnostics's market capitalization?
- Lucid Diagnostics (LUCD) reported market capitalization of $195.92M in Q1 2026.
- How has Lucid Diagnostics's market capitalization changed year-over-year?
- Lucid Diagnostics's market capitalization increased by 44.9% year-over-year, from $135.22M to $195.92M.
- What is the long-term trend for Lucid Diagnostics's market capitalization?
- Over 4 years (2021 to 2025), Lucid Diagnostics's market capitalization has grown at a -6.7% compound annual growth rate (CAGR), from $188.61M to $142.9M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.